MILabs, B.V. the Netherlands‐based innovator and manufacturer of pre‐clinical SPECT/PET/CT imaging devices used in biomedical research, today announces the release of the new mini product family ‐ an easy‐to‐use series of benchtop SPECT and PET imagers for small animals that combine simplified workflow, compact dimensions and affordable pricing to bring high‐performance SPECT/PET within everyone’s reach.

Analogic Corporation (Nasdaq:ALOG), enabling the world's medical imaging and aviation security technology, announced today that it will showcase its full suite of ultrasound imaging solutions, which offer clinicians a potentially faster and easier way to maximize ultrasound performance in urology and renal imaging, at the American Urological Association (AUA) Annual Meeting, May 4-8, in San Diego.

Viztek, a leading provider of complete digital software and hardware diagnostic imaging solutions, introduces the Leggera Wireless Panel, expanding the Leggera DR (Direct Radiography) Solutions product line to now include the lightest - 6.1 lb, ISO 4090 cassette size- wireless panel available to the market.

Carestream has been awarded a three-year agreement by Novation, a leading healthcare supply chain expertise and contracting company, to offer CARESTREAM Vue RIS+PACS, CARESTREAM Cardiology PACS and CARESTREAM Vue for Vendor-Neutral Archive to the members Novation serves.

Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products with an emphasis on serving the healthcare needs of women, today announced the publication of the final results of a large-scale prospective study comparing breast cancer screening using Hologic’s 2D mammography plus tomosynthesis (Breast Tomosynthesis) with conventional 2D mammography published online in advance of print by The Lancet Oncology.

Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced an important milestone for its Phase 3 flurpiridaz F 18 clinical program.

Navidea Biopharmaceuticals, Inc. (NYSE MKT:  NAVB), a biopharmaceutical company focused on the development and commercialization of precision diagnostic radiopharmaceuticals, today announced the U.S. launch of Lymphoseek® (technetium Tc 99m tilmanocept) Injection for use in lymphatic mapping procedures that are performed to help in the diagnostic evaluation of potential cancer spread for patients with breast cancer and melanoma.

ZONARE Medical Systems, the pioneer and developer of next generation ultrasound technology, is experiencing significant growth in the expanding vascular healthcare market with several customers purchasing additional ZONARE systems to support practice growth.